跳至主要内容
临床试验/ISRCTN52651778
ISRCTN52651778已完成未知

TRIal designs for DElivery of Novel Therapies for Neurodegeneration

Cardiff University0 个研究点目标入组 22 人开始时间: 2018年4月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
22

研究概览

简要总结

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33543141/ protocol (added 08/02/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Confirmed diagnosis of HD through genetic testing (CAG=39)
  • 2. =18 years of age
  • 3. Stage I or II disease (assessed using the Total Functional Capacity Scale with a score equal to 12 or below) and diagnosed as having motor onset
  • 4. Participant is ambulatory

排除标准

  • 1. People without capacity to consent to the trial
  • 2. Any ongoing major psychiatric disorder that would preclude the ability to take part in functional assessments and the ability to give informed consent
  • 3. Lack of carer, significant other or family member to support attendance at regular assessments.
  • Exclusion criteria for the surgical intervention are:
  • 4. Participants on any long-term anticoagulant medication (to include aspirin, warfarin, clexane)
  • 5. Any significant medical condition that would compromise the safety of anaesthesia and/ or surgery including; Q-T interval prolongation, torsades des pointes or ventricular arrhythmia
  • 6. Participants not deemed to be suitable for transplant surgery (e.g. inadequate striatal volume on MRI)
  • 7. Pregnancy and breastfeeding
  • Added 31/07/2019: 8. Previous immunizing event such as blood transfusion or previous transplant
  • 9. Contraindications to 3T MRI (such as a fitted pacemaker)
  • 10. Contraindications to PET
  • 11. Any contraindication to immunosuppressive therapy
  • 12. Positive blood tests for; Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), active Cytomegalovirus (CMV)infection, active Toxoplasma Gondii (Toxo G), Human T-cell lymphotropic virus type 1 (HTLV 1), serology for active treponema pallidum
  • 13. Women of childbearing potential and male participants with partners of childbearing potential who will not commit to the prevention of and active monitoring for pregnancy by using a highly effective form of contraception and undertaking regular pregnancy tests whilst enrolled in the study/or on immunosuppressant

研究者

相似试验